These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39024624)

  • 1. Cost-effectiveness of seasonal influenza vaccination in WHO-defined high-risk populations in Bangladesh.
    Hassan MZ; Jubayer Biswas MAA; Shirin T; Rahman M; Chowdhury F; Azziz-Baumgartner E; Davis WW; Hussain M
    J Glob Health; 2024 Jul; 14():04126. PubMed ID: 39024624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccination for heart failure patients: a cost-effectiveness analysis from the perspective of Chinese healthcare system.
    Zhao M; Liu F; Wang L; Chen D
    Front Public Health; 2024; 12():1348207. PubMed ID: 39185111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis.
    Wang Q; Jin H; Yang L; Jin H; Lin L
    Infect Dis Poverty; 2023 Oct; 12(1):92. PubMed ID: 37821942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-effective analysis of seasonal influenza vaccine in elderly Chinese population].
    Chen C; Liu GE; Wang MJ; Gao TF; Jia HP; Yang H; Feng LZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):993-999. PubMed ID: 31607044
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
    Ortega-Sanchez IR; Mott JA; Kittikraisak W; Khanthamaly V; McCarron M; Keokhonenang S; Ounaphom P; Pathammavong C; Phounphenghack K; Sayamoungkhoun P; Chanthavilay P; Bresee J; Tengbriacheu C
    Vaccine; 2021 Dec; 39(52):7633-7645. PubMed ID: 34802790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K.
    Meier G; Gregg M; Poulsen Nautrup B
    J Med Econ; 2015; 18(9):746-61. PubMed ID: 25903831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women.
    Xu J; Zhou F; Reed C; Chaves SS; Messonnier M; Kim IK
    Vaccine; 2016 Jun; 34(27):3149-3155. PubMed ID: 27161997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability, cost-effectiveness, and capacity of a facility-based seasonal influenza vaccination among high-risk groups: a study protocol in selected tertiary care hospitals of Bangladesh.
    Hassan MZ; Biswas MAAJ; Rahman M; Shoshi HR; Pyash AS; Islam MA; Haque MA; Parvin SR; Hossen MT; Hussain M; Rahman M; Shirin T; Chowdhury F
    BMC Public Health; 2024 Jan; 24(1):242. PubMed ID: 38245668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
    Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
    Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme.
    Edoka I; Kohli-Lynch C; Fraser H; Hofman K; Tempia S; McMorrow M; Ramkrishna W; Lambach P; Hutubessy R; Cohen C
    Vaccine; 2021 Jan; 39(2):412-422. PubMed ID: 33272702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
    Lugnér AK; van Boven M; de Vries R; Postma MJ; Wallinga J
    BMJ; 2012 Jul; 345():e4445. PubMed ID: 22791791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
    Brydak L; Roiz J; Faivre P; Reygrobellet C
    Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives.
    de Fougerolles TR; Baïssas T; Perquier G; Vitoux O; Crépey P; Bartelt-Hofer J; Bricout H; Petitjean A
    BMC Public Health; 2024 May; 24(1):1222. PubMed ID: 38702667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling.
    Dawa J; Emukule GO; Barasa E; Widdowson MA; Anzala O; van Leeuwen E; Baguelin M; Chaves SS; Eggo RM
    BMC Med; 2020 Aug; 18(1):223. PubMed ID: 32814581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
    Yang MC; Tan EC; Su JJ
    Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.
    de Boer PT; Backer JA; van Hoek AJ; Wallinga J
    BMC Med; 2020 Jan; 18(1):11. PubMed ID: 31931789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.
    Prosser LA; Lavelle TA; Fiore AE; Bridges CB; Reed C; Jain S; Dunham KM; Meltzer MI
    PLoS One; 2011; 6(7):e22308. PubMed ID: 21829456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children ≤60 months of age.
    Kittikraisak W; Suntarattiwong P; Ditsungnoen D; Pallas SE; Abimbola TO; Klungthong C; Fernandez S; Srisarang S; Chotpitayasunondh T; Dawood FS; Olsen SJ; Lindblade KA
    PLoS One; 2017; 12(8):e0183391. PubMed ID: 28837594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of influenza vaccination during pregnancy in Japan.
    Hoshi SL; Shono A; Seposo X; Okubo I; Kondo M
    Vaccine; 2020 Oct; 38(46):7363-7371. PubMed ID: 33020012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis.
    Yang J; Atkins KE; Feng L; Baguelin M; Wu P; Yan H; Lau EHY; Wu JT; Liu Y; Cowling BJ; Jit M; Yu H
    BMC Med; 2020 Apr; 18(1):90. PubMed ID: 32284056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.